Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-09-021808
Filing Date
2009-11-05
Accepted
2009-11-05 21:37:15
Documents
1
Period of Report
2009-11-03

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 26835
  Complete submission text file 0001225208-09-021808.txt   28729
Mailing Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100 908 423 1688
Merck & Co. Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CHARLES RIVER LABORATORIES 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address
THIER SAMUEL O MD (Reporting) CIK: 0001144773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 091162627